Log In
Print
BCIQ
Print
Print this Print this
 

AlloMap Molecular Expression Test

  Manage Alerts
Collapse Summary General Information
Company CareDx Inc.
DescriptionNon-invasive multi-gene expression profiling blood diagnostic
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationTransplant, Diagnostic
Indication DetailsIdentify heart transplant patients with stable allograft function who have a low probability of moderate/severe acute cellular rejection; Monitoring asymptomatic heart transplant patients for acute rejection after transplantation
Regulatory Designation

Partner

Diaxonhit


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today